"Advances in Health is a clinical research center, established in 1998, offering comprehensive services to pharmaceutical companies and conducting Phase I, II & III trials, on a broad range of therapeutic areas. Clinical studies are an opportunity for patients to receive cutting edge treatments, which are new or experimental and not currently available to the general public. Clinical trials allow patients to learn more about their disease, due to the frequency of the visits and the quality time spent with the study physician and research staff."

During the past decade, Advances in Health conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 15 clinical trials were completed, i.e. on average, 125% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 11 clinical trials were completed. i.e. 366.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Advances in Health" #1 sponsor was "Repros Therapeutics Inc." with 4 trials, followed by "Pfizer" with 3 trials sponsored, "Astellas Pharma Global Development, Inc." with 2 trials sponsored, "Sebela Women's Health Inc." with 2 trials sponsored and "TherapeuticsMD" with 2 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Advances in Health" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "PRA Health Sciences" with 1 trials as a collaborator, "Procter and Gamble" with 1 trials as a collaborator and "Synteract, Inc." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Advances in Health" are "Overactive Bladder" (3 trials), "Uterine Fibroids" (3 trials), "Hot Flashes" (2 trials), "Menopause" (2 trials) and "Women at Risk for Pregnancy" (2 trials). Many other conditions were trialed in "Advances in Health" in a lesser frequency.

Most popular intervention types in "Advances in Health" are "Drug" (17 trials), "Biological" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Estradiol" (2 trials), "Tolterodine Tartrate ER" (2 trials), "placebo" (2 trials) and "Androxal" (1 trials). Other intervention names were less common.

The vast majority of trials in "Advances in Health" are 11 trials for "Female" genders, 6 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Advances in Health". 1 are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Advances in Health, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Advances in Health, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".